Literature DB >> 16230022

MICAL flavoprotein monooxygenases: expression during neural development and following spinal cord injuries in the rat.

R Jeroen Pasterkamp1, Hai-ning Dai, Jonathan R Terman, Karl J Wahlin, Byung Kim, Barbara S Bregman, Phillip G Popovich, Alex L Kolodkin.   

Abstract

MICALs comprise of a family of phylogenetically conserved, multidomain cytosolic flavoprotein monooxygenases. Drosophila (D-)MICAL binds the neuronal Sema1a receptor PlexA, and D-MICAL-PlexA interactions are required in vivo for Sema1a-induced axon repulsion. The biological functions of vertebrate MICAL proteins, however, remain unknown. Here, we describe three rodent MICAL genes and analyze their expression in the intact rat nervous system and in two models of spinal cord injury. MICAL-1, -2, and -3 expression patterns in the embryonic, postnatal, and adult nervous system support the idea that MICALs play roles in neural development and plasticity. In addition, MICAL expression is elevated in oligodendrocytes and in meningeal fibroblasts at sites of spinal cord injury but is unchanged in lesioned corticospinal tract neurons. Furthermore, we find that the selective monooxygenase inhibitor EGCG attenuates the repulsive effects of Sema3A and Sema3F in vitro, but not those of several other repulsive cues and substrates. These results implicate MICALs in neuronal regeneration and support the possibility of employing EGCG to attenuate Sema3-mediated axon repulsion in the injured spinal cord.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230022     DOI: 10.1016/j.mcn.2005.09.001

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  32 in total

Review 1.  Semaphorins in angiogenesis and tumor progression.

Authors:  Gera Neufeld; Adi D Sabag; Noa Rabinovicz; Ofra Kessler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  Semaphorins in axon regeneration: developmental guidance molecules gone wrong?

Authors:  R Jeroen Pasterkamp; Joost Verhaagen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

3.  Release of MICAL autoinhibition by semaphorin-plexin signaling promotes interaction with collapsin response mediator protein.

Authors:  Eric F Schmidt; Sang-Ohk Shim; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2008-02-27       Impact factor: 6.167

Review 4.  Getting neural circuits into shape with semaphorins.

Authors:  R Jeroen Pasterkamp
Journal:  Nat Rev Neurosci       Date:  2012-08-16       Impact factor: 34.870

5.  Important relationships between Rab and MICAL proteins in endocytic trafficking.

Authors:  Juliati Rahajeng; Sai Srinivas Panapakkam Giridharan; Bishuang Cai; Naava Naslavsky; Steve Caplan
Journal:  World J Biol Chem       Date:  2010-08-26

6.  MICAL-1 is a negative regulator of MST-NDR kinase signaling and apoptosis.

Authors:  Yeping Zhou; Youri Adolfs; W W M Pim Pijnappel; Stephen J Fuller; Roel C Van der Schors; Ka Wan Li; Peter H Sugden; August B Smit; Alexander Hergovich; R Jeroen Pasterkamp
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

Review 7.  MICAL-family proteins: Complex regulators of the actin cytoskeleton.

Authors:  Sai Srinivas Panapakkam Giridharan; Steve Caplan
Journal:  Antioxid Redox Signal       Date:  2013-08-17       Impact factor: 8.401

Review 8.  Extracellular inhibitors, repellents, and semaphorin/plexin/MICAL-mediated actin filament disassembly.

Authors:  Ruei-Jiun Hung; Jonathan R Terman
Journal:  Cytoskeleton (Hoboken)       Date:  2011-08-25

9.  Differential regulation of actin microfilaments by human MICAL proteins.

Authors:  Sai Srinivas Panapakkam Giridharan; Jennifer L Rohn; Naava Naslavsky; Steve Caplan
Journal:  J Cell Sci       Date:  2012-02-13       Impact factor: 5.285

Review 10.  Regulated methionine oxidation by monooxygenases.

Authors:  Bruno Manta; Vadim N Gladyshev
Journal:  Free Radic Biol Med       Date:  2017-02-14       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.